Prixa Expands In Indonesia

Indonesian healthcare startup - Prixa - has raised $3 million led by MDI Ventures and the Trans-Pacific Technology Fund (TPTF), with participation from returning investors including Siloam Hospitals Group. This brings Prixa’s total raised to $4.5 million since it launched in 2019. The new funding will enable Prixa to scale its platform and customer base. Prixa uses a B2B model, partnering with healthcare payers like insurance providers and corporations. Through its B2B customers, it currently serves about 10 million patients.

Prixa currently works with four major insurers and has six additional insurers in its short-term pipeline. It also works with Indonesia’s largest third-party administrators, allowing it to reach more policyholders.

Prixa’s platform includes a digital health assistant to answer patients’ questions, telemedicine consultations, pharmacy deliveries and on-demand lab diagnostics. Usage increased during the COVID-19 pandemic as more patients sought online consultations for primary care.

Other telehealth startups in Indonesia include Halodoc and Alodokter (which is also backed by MDI). Both connect patients directly with healthcare and insurance providers. Prixa differentiates by focusing on greater cost control for healthcare payers and positioning itself as a digital primary care platform.

Prixa symptomatically manage patients outside of tertiary care facilities and caring for chronic non-communicable diseases online. Prixa is able to effectively reduce the amount of outpatient claims and downstream inpatient cost incurred by healthcare payers. Additionally, the combination of a growing and robust medical database, as well as proven clinical guidelines, contribute to cost efficiency and service optimization through the standardization of treatment by our healthcare providers.